Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)

Table 3 Clinical characteristics of the study samples (N; percentages in parentheses)

	German reference men [n = 988]	German PC patients with scheduled radiotherapy [n = 121]	German PC patients with scheduled radical prostatectomy [n = 371]	p-values for differences between German RT and RP patients	Canadian PC patients with scheduled radiotherapy [n = 66]	Canadian PC patients with scheduled radical prostatectomy [n = 68]	p-values for differences between Canadian RT and RP patients
D'Amico Risk Score	Not			p < 0.001#
Low		39 (32.2)	24 (6.5)
Intermediate		39 (32.2)	46 (12.4)
High	applicable	43 (35.5)	301 (81.1)		-	-
Gleason score (pre-treatment) Mean ± SD	Not applicable	6.13 ± 1.33	6.35 ± 1.21	p < 0.096*	-	-
Highest recorded pre-treatment PSA [ng/ml] (mean ± SD)	Not applicable	13.7 ± 17.3	10.2 ± 17.9	p = 0.066*	14.3 ± 14.6	8.81 ± 6.9	p = 0.006*

ISSN: 1471-2407